-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Novel coronavirus pneumonia has a huge impact on the health of patients, with high morbidity and mortality
.
On the basis of this viral infection, alterations in the microbial ecology of the lung often exacerbate disease and increase host susceptibility to superinfection
Alterations in the microbial ecology of the lung often exacerbate disease and increase host susceptibility to superinfection
Pseudomonas aeruginosa is the top superinfection bacterium of SARS-CoV-2.
Fig.
1 Ring diagram and phylogenetic tree of LYSZa2 and LYSZa5
.
LYSZa2 and LYSZa5 with other
Fig.
Figure 2 Heatmap and PCoA plot of DEGs between genetic isolates and progeny isolates
.
Heatmap of significant DEGs in LYSZa3 and LYSZa2; B heatmap of significant DEGs in LYSZa6 compared to LYSZa5; C PCoA maps of DEGs based on DEGs in LYSZa3 and LYSZa2 groups using Bray Curtis dissimilarity method; Plot the D PCoA map of the LYSZa6 group and the LYSZa5 groupFigure 2 Heatmap and PCoA plot of DEGs between genetic isolates and progeny isolates
Table 1 Common gene mutations between LYSZa3 and LYSZa6
Table 1 Common gene mutations between LYSZa3 and LYSZa6Conclusions: Our study shows that SARS-CoV-2 infection can create a more livable lung environment, allowing bacterial pathogens with genetic characteristics suitable for chronic infection to rapidly adapt and evolve
.
.
Original source: Qu J, Cai Z, Duan X, et al.
Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients.
Leave a Comment